Case number 2023-2032
Astellas Pharma, Inc. v. Sandoz Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 14, 2023 | 29 | ORDER granting motion to extend time to file brief [25] filed by Appellants Astellas Pharma, Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. The opening brief is due 10/27/2023. No further extensions of time for the opening brief should be anticipated. Service as of this date by the Clerk of Court. [942625] [LMS] [Entered: 08/14/2023 09:57 AM] (2) |
| Aug 11, 2023 | 27 | Notice to Appellees Actavis Elizabeth LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Huahai US Inc., Prinston Pharmaceutical Inc., Solco Healthcare U.S., LLC, Teva Pharmaceuticals USA, Inc. and Zhejiang Huahai Pharmaceutical Co., Ltd.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 47.6 has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Please file promptly. Service as of this date by the Clerk of Court. [942239] [MMA] [Entered: 08/11/2023 09:31 AM] (0) |
| Aug 11, 2023 | 28 | REPLY of Appellants Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. and Astellas Pharma, Inc. to response [26]. Service: 08/11/2023 by email. [942412] [23-2032] [Paul Hughes] [Entered: 08/11/2023 02:39 PM] (8) |
| Aug 10, 2023 | 26 | RESPONSE of Appellees Lek Pharmaceuticals, d.d., Lupin Ltd., Lupin Pharmaceuticals, Inc., Sandoz Inc., Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc. to Doc No. [25]. Service: 08/10/2023 by email. [942178] [23-2032] [David Abramowitz] [Entered: 08/10/2023 05:34 PM] (20) |
| Aug 8, 2023 | 25 | MOTION of Appellants Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. and Astellas Pharma, Inc. to extend the time to 10/27/2023 to file brief. Service: 08/08/2023 by email. [941469] [23-2032] [Paul Hughes] [Entered: 08/08/2023 02:39 PM] (15) |
| Jul 10, 2023 | 21 | Entry of Appearance for Michael J. Gaertner; Hugh S. Balsam; David B. Abramowitz; Carolyn A. Blessing; Emily L. Savas; Jonathan B. Turpin as counsel for Appellees Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 07/10/2023 by email. [934952] [23-2032] [David Abramowitz] [Entered: 07/10/2023 11:11 AM] (2) |
| Jul 10, 2023 | 22 | Certificate of Interest for Appellees Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 07/10/2023 by email. [934955] [23-2032] [David Abramowitz] [Entered: 07/10/2023 11:13 AM] (4) |
| Jul 10, 2023 | 23 | Docketing Statement for the Appellees Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 07/10/2023 by email. [934958] [23-2032] [David Abramowitz] [Entered: 07/10/2023 11:15 AM] (3) |
| Jul 10, 2023 | 24 | Corrected Entry of Appearance for William Zimmerman; Carol Pitzel Cruz; Andrea Cheek as counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 07/10/2023 by email. [935219] [23-2032] [William Zimmerman] [Entered: 07/10/2023 05:18 PM] (2) |
| Jul 6, 2023 | 18 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc., Entry of Appearance [17], is not in compliance with the rules of this court (see attached). Compliant document due on 07/13/2023. Service as of this date by the Clerk of Court. [934371] [JPS] [Entered: 07/06/2023 02:18 PM] (2) |
| Jul 6, 2023 | 19 | ORDER consolidating appeals 23-2032, 23-2063, and 23-2089. Appellants' opening brief is due no later than August 28, 2023. Service as of this date by the Clerk of Court. [934452] [23-2032, 23-2063, 23-2089] [ALK] [Entered: 07/06/2023 03:59 PM] (2) |
| Jul 6, 2023 | 20 | Note to File: The following cases are consolidated: 23-2032 (Lead) with 23-2063, 23-2089 (Members). The parties must file all documents in the lead appeal only. [934454] [ALK] [Entered: 07/06/2023 04:03 PM] (0) |
| Jul 5, 2023 | 17 | Corrected Entry of Appearance for William Zimmerman, Carol Pitzel Cruz, Andrea Cheek as counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 07/05/2023 by email. [934020] [23-2032] This document is non-complaint. See Doc. No. [18] [William Zimmerman] [Entered: 07/05/2023 12:55 PM] (2) |
| Jun 30, 2023 | 8 | NOTICE OF NON-COMPLIANCE: The submission of , Entry of Appearance [4], is not in compliance with the rules of this court (see attached). Compliant document due on 07/10/2023. Service as of this date by the Clerk of Court. [933662] [JPS] [Entered: 06/30/2023 03:36 PM] (2) |
| Jun 30, 2023 | 9 | Entry of Appearance for William A. Rakoczy; Deanne M. Mazzochi; Rachel Pernic Waldron; Kevin P. Burke as counsel for Appellees Sandoz Inc. and Lek Pharmaceuticals, d.d.. Service: 06/30/2023 by email. [933701] [23-2032] [Kevin Burke] [Entered: 06/30/2023 05:19 PM] (2) |
| Jun 30, 2023 | 10 | Docketing Statement for the Appellees Sandoz Inc. and Lek Pharmaceuticals, d.d.. Service: 06/30/2023 by email. [933703] [23-2032] [Kevin Burke] [Entered: 06/30/2023 05:22 PM] (2) |
| Jun 30, 2023 | 11 | Certificate of Interest for Appellees Sandoz Inc. and Lek Pharmaceuticals, d.d.. Service: 06/30/2023 by email. [933704] [23-2032] [Kevin Burke] [Entered: 06/30/2023 05:25 PM] (3) |
| Jun 30, 2023 | 12 | Entry of Appearance for Paul W. Hughes; Jason A. Leonard; Simon Roberts; Daniel M. Silver as counsel for Appellants Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. and Astellas Pharma, Inc.. Service: 06/30/2023 by email. [933720] [23-2032] [Paul Hughes] [Entered: 06/30/2023 05:44 PM] (2) |
| Jun 30, 2023 | 13 | Docketing Statement for the Appellants Astellas Ireland Co., Ltd., Astellas Pharma, Inc. and Astellas Pharma Global Development, Inc.. Service: 06/30/2023 by email. [933726] [23-2032] [Paul Hughes] [Entered: 06/30/2023 05:49 PM] (2) |
| Jun 30, 2023 | 14 | Certificate of Interest for Appellants Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. and Astellas Pharma, Inc.. Service: 06/30/2023 by email. [933728] [23-2032] [Paul Hughes] [Entered: 06/30/2023 05:52 PM] (4) |
| Jun 30, 2023 | 15 | Notice of Related Case Information for Appellants Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. and Astellas Pharma, Inc.. Service: 06/30/2023 by email. [933729] [23-2032] [Paul Hughes] [Entered: 06/30/2023 05:54 PM] (3) |
| Jun 30, 2023 | 16 | Notice of Related Case Information for Appellees Sandoz Inc. and Lek Pharmaceuticals, d.d.. Service: 06/30/2023 by email. [933731] [23-2032] [Kevin Burke] [Entered: 06/30/2023 06:42 PM] (3) |
| Jun 29, 2023 | 3 | Documents from United States District Court for the District of Delaware. [933236] [ALK] [Entered: 06/29/2023 03:01 PM] (13) |
| Jun 29, 2023 | 4 | Entry of Appearance for William Zimmerman; Carol Pitzel Cruz; Andrea Cheek as counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 06/29/2023 by email. [933348] [23-2032] This document is non-compliant. See Doc. No. [8] [William Zimmerman] [Entered: 06/29/2023 06:23 PM] (2) |
| Jun 29, 2023 | 5 | Docketing Statement for the Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 06/29/2023 by email. [933349] [23-2032] [William Zimmerman] [Entered: 06/29/2023 06:25 PM] (2) |
| Jun 29, 2023 | 6 | Certificate of Interest for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 06/29/2023 by email. [933350] [23-2032] [William Zimmerman] [Entered: 06/29/2023 06:27 PM] (4) |
| Jun 29, 2023 | 7 | Notice of Related Case Information for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 06/29/2023 by email. [933351] [23-2032] [William Zimmerman] [Entered: 06/29/2023 06:28 PM] (2) |
| Jun 26, 2023 | 2 | Notice from Appellees Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc. regarding postjudgment motions. Service: 06/26/2023 by email. [932362] [23-2032] [David Abramowitz] [Entered: 06/26/2023 04:32 PM] (10) |
| Jun 16, 2023 | 1 | Appeal docketed. Received: 06/13/2023. [930642]Entry of Appearance due 06/30/2023. Certificate of Interest is due on 06/30/2023. Docketing Statement due 06/30/2023. Appellants' brief is due 08/15/2023. [MMA] [Entered: 06/16/2023 01:09 PM] (130) |
